多模态数据整合提升抑郁症两年自然病程预测并揭示缓解特征
该研究用机器学习在643例当前重性抑郁障碍(MDD)患者中训练并交叉验证预测模型,随后在161例MDD个体中测试。结果显示,将基线血浆蛋白质组数据加入临床变量可显著改善2年缓解预测(AUC 0.63 vs. 0.78,p = .013),其他组学数据加入未见显著改善。蛋白质组特征涉及炎症反应和脂质代谢,纤维蛋白原变量重要性最高,模型预测平衡准确率71%优于精神科医生的55%。
要点
- 蛋白质组数据单独预测2年缓解的AUC为0.68,为最佳单模态数据。
- 蛋白质组加入临床数据显著提升2年缓解预测(AUC 0.63 vs. 0.78,p = .013)。
- 模型预测平衡准确率71%优于精神科医生的55%。
核心结论
- 将蛋白质组数据而非其他组学数据加入临床基线变量,可提升MDD两年缓解状态的个体化预测。
- 研究揭示了一个具有临床潜力的两年MDD缓解多模态特征。
研究设计与样本
- 数据驱动的机器学习预测研究,训练和交叉验证样本为643例当前MDD患者(2年缓解n = 325)。
- 模型随后在161例MDD个体(2年缓解n = 82)中测试性能。
主要发现
- 蛋白质组数据单独预测2年缓解的受试者工作特征曲线下面积(AUC)为0.68,为最佳单模态预测。
- 蛋白质组加入临床数据后2年MDD缓解预测AUC从0.63提升至0.78(p = .013)。
- 其他组学数据加入临床数据未显著改善模型性能。
- 蛋白质组分析物涉及炎症反应和脂质代谢,纤维蛋白原水平变量重要性最高,其次为症状严重程度。
- 机器学习模型预测2年缓解的平衡准确率为71%,精神科医生为55%。
关键数值与推荐
- 蛋白质组单独预测2年缓解AUC = 0.68。
- 临床+蛋白质组预测2年缓解AUC = 0.78,临床数据AUC = 0.63,p = .013。
- 机器学习模型平衡准确率71%,精神科医生55%。
临床怎么用
- 基线血浆蛋白质组联合临床变量或有助于个体化预测MDD两年缓解状态。
- 纤维蛋白原水平和症状严重程度是预测缓解的重要特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The ability to predict the disease course of individuals with major depressive disorder (MDD) is essential for optimal treatment planning. Here, we used a data-driven machine learning approach to assess the predictive value of different sets of biological data (whole-blood proteomics, lipid metabolomics, transcriptomics, genetics), both separately and added to clinical baseline variables, for the longitudinal prediction of 2-year remission status in MDD at the individual-subject level. METHODS: Prediction models were trained and cross-validated in a sample of 643 patients with current MDD (2-year remission n = 325) and subsequently tested for performance in 161 individuals with MDD (2-year remission n = 82). RESULTS: Proteomics data showed the best unimodal data predictions (area under the receiver operating characteristic curve = 0.68). Adding proteomic to clinical data at baseline significantly improved 2-year MDD remission predictions (area under the receiver operating characteristic curve = 0.63 vs. 0.78, p = .013), while the addition of other omics data to clinical data did not yield significantly improved model performance. Feature importance and enrichment analysis revealed that proteomic analytes were involved in inflammatory response and lipid metabolism, with fibrinogen levels showing the highest variable importance, followed by symptom severity. Machine learning models outperformed psychiatrists' ability to predict 2-year remission status (balanced accuracy = 71% vs. 55%). CONCLUSIONS: This study showed the added predictive value of combining proteomic data, but not other omics data, with clinical data for the prediction of 2-year remission status in MDD. Our results reveal a novel multimodal signature of 2-year MDD remission status that shows clinical potential for individual MDD disease course predictions from baseline measurements.
引用
- Habets PC, Thomas RM, Milaneschi Y, et al. Multimodal Data Integration Advances Longitudinal Prediction of the Naturalistic Course of Depression and Reveals a Multimodal Signature of Remission During 2-Year Follow-up. Biol Psychiatry. 2023. PMID: 37330166. doi:10.1016/j.biopsych.2023.05.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。